ARCHIVES

In Brief: Schweitzer ACS President, Dodd President Elect, FDA Commissioner Resigns Abruptly

This article is from The Cancer Letter archive.

Vol. 15 No. 44 | November 17, 1989

Download PDF Visit The Full Archive

Related Articles

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

June 2, 2006

NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent

December 27, 2013

NCAB forms subcommittee to develop NCI biomedical technologies initiative.

September 26, 2003

NCI Requests $5.69 Billion To Seize Opportunities In FY03.

January 11, 2002

FDA Faces Severe Regulatory, Scientific Needs, Report Finds.

February 1, 2008

House committee Seeks $239 Million Cut In Clinton’s NIH Budget

March 11, 1994